There have been 50 recent insider transactions recorded for Catalent, Inc. (CTLT), including 18 buys and 32 sells. Total insider buying was valued at RSU Award and total insider selling at $11.65M.
Notable insiders with recent activity include Stahl Jack L, Classon Rolf A, Damelio Frank A. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CTLT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-12-18 |
Stahl Jack L |
Director |
Return of Shares |
47,984 |
- |
- |
- |
| 2024-12-18 |
Classon Rolf A |
Director |
Return of Shares |
47,984 |
- |
- |
- |
| 2024-12-18 |
Damelio Frank A |
Director |
Return of Shares |
12,635 |
- |
- |
- |
| 2024-12-18 |
Morel Donald E Jr |
Director |
Return of Shares |
70,118 |
- |
- |
- |
| 2024-12-18 |
Lucier Gregory T |
Director |
Return of Shares |
36,914 |
- |
- |
- |
| 2024-12-18 |
Greisch John J |
Executive Chair |
Return of Shares |
127,096 |
$48.98 |
$6.23M |
- |
| 2024-12-18 |
Carroll J Martin |
Director |
Return of Shares |
32,734 |
- |
- |
- |
| 2024-12-18 |
Masanovich Matti |
SVP, Chief Financial Officer |
Return of Shares |
81,082 |
$44.76 |
$3.63M |
- |
| 2024-12-18 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
Return of Shares |
21,562 |
- |
- |
- |
| 2024-12-18 |
Evoli Lisa |
SVP, Chief HR Officer |
Return of Shares |
12,032 |
- |
- |
- |
| 2024-12-18 |
Maselli Alessandro |
President & CEO |
Return of Shares |
113,224 |
- |
- |
- |
| 2024-12-18 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
Return of Shares |
12,938 |
- |
- |
- |
| 2024-12-18 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
Return of Shares |
14,265 |
- |
- |
- |
| 2024-12-18 |
Okey Stephanie |
Director |
Return of Shares |
12,635 |
- |
- |
- |
| 2024-12-18 |
Hatzfeld Michael |
Chief Accounting Officer |
Return of Shares |
3,144 |
- |
- |
- |
| 2024-12-18 |
Barg Steven |
Director |
Return of Shares |
12,374 |
- |
- |
- |
| 2024-12-18 |
Barber Michael J |
Director |
Return of Shares |
18,052 |
- |
- |
- |
| 2024-12-18 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
Return of Shares |
10,669 |
$46.51 |
$496.22K |
- |
| 2024-12-18 |
Ryan Michelle R |
Director |
Return of Shares |
10,835 |
- |
- |
- |
| 2024-12-18 |
Mcerlane David |
Group President, Biologics |
Return of Shares |
11,426 |
- |
- |
- |
| 2024-11-11 |
Ryan Michelle R |
Director |
Informative Sell |
2,800 |
$59.70 |
$167.16K |
10,835 |
| 2024-10-30 |
Stahl Jack L |
Director |
RSU Award |
4,663 |
- |
- |
47,984 |
| 2024-10-30 |
Classon Rolf A |
Director |
RSU Award |
4,663 |
- |
- |
47,984 |
| 2024-10-30 |
Damelio Frank A |
Director |
RSU Award |
4,663 |
- |
- |
12,635 |
| 2024-10-30 |
Morel Donald E Jr |
Director |
RSU Award |
4,663 |
- |
- |
70,118 |
| 2024-10-30 |
Lucier Gregory T |
Director |
RSU Award |
4,663 |
- |
- |
36,914 |
| 2024-10-30 |
Carroll J Martin |
Director |
RSU Award |
4,663 |
- |
- |
32,734 |
| 2024-10-30 |
Okey Stephanie |
Director |
RSU Award |
4,663 |
- |
- |
12,635 |
| 2024-10-30 |
Barg Steven |
Director |
RSU Award |
4,663 |
- |
- |
12,374 |
| 2024-10-30 |
Barber Michael J |
Director |
RSU Award |
4,663 |
- |
- |
18,052 |
| 2024-10-30 |
Ryan Michelle R |
Director |
RSU Award |
4,663 |
- |
- |
13,635 |
| 2024-10-18 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
Informative Sell |
320 |
$59.97 |
$19.19K |
23,967 |
| 2024-09-26 |
Mcerlane David |
Group President, Biologics |
Informative Sell |
1,994 |
$59.97 |
$119.58K |
36,304 |
| 2024-08-02 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
Informative Sell |
1,169 |
$59.55 |
$69.61K |
113,724 |
| 2024-08-02 |
Evoli Lisa |
SVP, Chief HR Officer |
Informative Sell |
3,859 |
$59.67 |
$230.27K |
39,366 |
| 2024-08-02 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
Informative Sell |
666 |
$59.55 |
$39.66K |
39,635 |
| 2024-08-02 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
Informative Sell |
608 |
$59.58 |
$36.22K |
24,287 |
| 2024-08-02 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
Informative Sell |
662 |
$59.56 |
$39.43K |
29,974 |
| 2024-07-29 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
Informative Sell |
349 |
$58.70 |
$20.49K |
114,893 |
| 2024-07-29 |
Maselli Alessandro |
President & CEO |
Informative Sell |
9,088 |
$58.76 |
$534.01K |
177,521 |
| 2024-07-29 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
Informative Sell |
283 |
$58.69 |
$16.61K |
40,301 |
| 2024-07-29 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
Informative Sell |
206 |
$58.67 |
$12.09K |
30,636 |
| 2024-07-26 |
Greisch John J |
Executive Chair |
RSU Award |
63,736 |
- |
- |
79,932 |
| 2024-07-26 |
Masanovich Matti |
SVP, Chief Financial Officer |
RSU Award |
42,604 |
- |
- |
76,475 |
| 2024-07-26 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
RSU Award |
18,746 |
- |
- |
115,242 |
| 2024-07-26 |
Evoli Lisa |
SVP, Chief HR Officer |
RSU Award |
15,338 |
- |
- |
43,225 |
| 2024-07-26 |
Maselli Alessandro |
President & CEO |
RSU Award |
98,671 |
- |
- |
186,609 |
| 2024-07-26 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
RSU Award |
11,078 |
- |
- |
40,584 |
| 2024-07-26 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
RSU Award |
17,042 |
- |
- |
24,895 |
| 2024-07-26 |
Hatzfeld Michael |
Chief Accounting Officer |
RSU Award |
5,624 |
- |
- |
13,532 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
